Trends in diabetes incidence among 7 million insured adults, 2006-2011

American Journal of Epidemiology

Volumn 181, Issue 1, 2015, Pages 32-39

  Nichols, Gregory A ^a   Schroeder, Emily B ^b   Karter, Andrew J ^c   Gregg, Edward W ^d   Desai, Jay ^e   Lawrence, Jean M ^f   O'Connor, Patrick J ^e   Xu, Stanley ^b   Newton, Katherine M ^g   Raebel, Marsha A ^b   Pathak, Ram D ^h   Waitzfelder, Beth ⁱ   Segal, Jodi ^j   Lafata, Jennifer Elston ^k,l   Butler, Melissa G ^m   Lester Kirchner, H ⁿ   Thomas, Abraham ^k   Steiner, John F ^b  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b KAISER PERMANENTE   (United States)

^c DIVISION OF RESEARCH   (United States)

^d NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^e HEALTHPARTNERS INSTITUTE   (United States)

^f Department of Research and Evaluation Kaiser Permanente Southern California ^*  (United States)

^g GROUP HEALTH RESEARCH INSTITUTE   (United States)

^h MARSHFIELD CLINIC   (United States)

ⁱ KAISER PERMANENTE   (United States)

^j JOHNS HOPKINS UNIVERSITY   (United States)

^k HENRY FORD HEALTH SYSTEM   (United States)

^l VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^m Center for Health Research   (United States)

ⁿ GEISINGER HEALTH SYSTEM   (United States)

more..

Author keywords

Diabetes mellitus; Glycated hemoglobin; Hemoglobin A1c; Incidence; Trends

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; ANNUAL VARIATION; COHORT ANALYSIS; DIABETES; ESTIMATION METHOD; HEALTH RISK; HEALTH SURVEY;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CAUCASIAN; COHORT ANALYSIS; DIABETES MELLITUS; ELECTRONIC MEDICAL RECORD; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEALTH CARE UTILIZATION; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; INCIDENCE; INTEGRATED HEALTH CARE SYSTEM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; RACE DIFFERENCE; SEX DIFFERENCE; TREND STUDY; UNITED STATES; VERY ELDERLY; ANALYSIS; BLOOD ANALYSIS; ETHNOLOGY; TRENDS;

UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BLOOD CHEMICAL ANALYSIS; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; MALE; MIDDLE AGED; UNITED STATES;

EID: 84922421023     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwu255     Document Type: Article

References (42)

1. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36(4):1033-1046.
2. International Diabetes Federation. Diabetes Atlas. 6th ed. Brussels, Belgium: International Diabetes Federation; 2013.
3. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011; 378(9785):31-40.
4. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295(13):1549-1555.
5. Flegal KM, Carroll MD, Kit BK, et al. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012;307(5):491-497.
6. Geiss LS, Pan L, Cadwell B, et al. Changes in incidence of diabetes in U.S. adults, 1997-2003. Am J Prev Med. 2006; 30(5):371-377.
7. Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care. 2009;32(2):287-294.
8. Centers for Disease Control and Prevention. Diabetes data and trends. http://www.cdc.gov/diabetes/statistics/incidence- national.htm. Updated October 5, 2012. Accessed November 12, 2013.
9. Carstensen B, Kristensen JK, Ottosen P, et al. The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Steering Group of the National Diabetes Register. Diabetologia. 2008;51(12):2187-2196.
10. Holden SH, Barnett AH, Peters JR, et al. The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010. Diabetes Obes Metab. 2013;15(9):844-852.
11. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32(7):1327-1334.
12. World Health Organization. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. Geneva, Switzerland: World Health Organization; 2011. http://www. who.int/diabetes/publications/report-hba1c-2011.pdf. Accessed November 12, 2013.
13. Mostafa SA, Khunti K, Srinivasan BT, et al. The potential impact and optimal cut-points of using glycated haemoglobin, HbA1c, to detect people with impaired glucose regulation in a UK multi-ethnic cohort. Diabetes Res Clin Pract. 2010;90(1): 100-108.
14. Hornbrook MC, Hart G, Ellis JL, et al. Building a virtual cancer research organization. J Natl Cancer Inst Monogr. 2005;35: 12-25.
15. Nichols GA, Desai J, Elston Lafata J, et al. Construction of a multisite DataLink using electronic health records for the identification, surveillance, prevention, and management of diabetes mellitus: the SUPREME-DM project. Prev Chronic Dis. 2012;9:E110.
16. Koebnick C, Langer-Gould AM, Gould MK, et al. Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Perm J. 2012;16(3):37-41.
17. Saydah SH, Geiss LS, Tierney E, et al. Review of the performance of methods to identify diabetes cases among vital statistics, administrative, and survey data. Ann Epidemiol. 2004; 14(7):507-516.
18. Zgibor JC, Orchard TJ, Saul M, et al. Developing and validating a diabetes database in a large health system. Diabetes Res Clin Pract. 2007;75(3):313-319.
19. Miller DR, Safford MM, Pogach LM. Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care. 2004;27(suppl 2):B10-B21.
20. Brown JB, Nichols GA, Glauber HS. Case-control study of 10 years of comprehensive diabetes care. West J Med. 2000; 172(2):85-90.
21. Selby JV, Ray GT, Zhang D, et al. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care. 1997;20(9):1396-1402.
22. O'Connor PJ, Rush WA, Pronk NP, et al. Identifying diabetes mellitus or heart disease among health maintenance organization members: sensitivity, specificity, predictive value, and cost of survey and database methods. Am J Manag Care. 1998;4(3):335-342.
23. Newton KM, Wagner EH, Ramsey SD, et al. The use of automated data to identify complications and comorbidities of diabetes: a validation study. J Clin Epidemiol. 1999;52(3): 199-207.
24. Baker AM, Lafata JE, Ward RE, et al. A Web-based diabetes care management support system. Jt Comm J Qual Improv. 2001;27(4):179-190.
25. Schenker N, Gentleman JF. On judging the significance of differences by examining the overlap between confidence intervals. Am Stat. 2001;55(3):182-186.
26. Fox CS, Pencina MJ, Meigs JB, et al. Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. Circulation. 2006;113(25): 2914-2918.
27. Brancati FL, Kao WH, Folsom AR, et al. Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA. 2000; 283(17):2253-2259.
28. Centers for Disease Control and Prevention. Annual number (in thousands) of new cases of diagnosed diabetes among adults aged 18-79 years, United States, 1980-2011. http://www.cdc. gov/diabetes/statistics/incidence/fig1.htm. Updated September 24, 2012. Accessed November 12, 2013.
29. Tabaei BP, Chamany S, Driver CR, et al. Incidence of self-reported diabetes in New York City, 2002, 2004, and 2008. Prev Chronic Dis. 2012;9:E114.
30. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(suppl 1):S62-S69.
31. Sacks DB. A1C versus glucose testing: a comparison. Diabetes Care. 2011;34(2):518-523.
32. van 't Riet E, Alssema M, Rijkelijkhuizen JM, et al. Relationship between A1C and glucose levels in the general Dutch population: the new Hoorn Study. Diabetes Care. 2010; 33(1):61-66.
33. Malkani S, Mordes JP. The implications of using hemoglobin A1C for diagnosing diabetes mellitus. Am J Med. 2011;124(5): 395-401.
34. Olson DE, Rhee MK, Herrick K, et al. Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care. 2010;33(10):2184-2189.
35. Pajunen P, Peltonen M, Eriksson JG, et al. HbA(1c) in diagnosing and predicting type 2 diabetes in impaired glucose tolerance: the Finnish Diabetes Prevention Study. Diabet Med. 2011;28(1):36-42.
36. Saudek CD, Herman WH, Sacks DB, et al. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab. 2008;93(7):2447-2453.
37. Karter AJ, Schillinger D, Adams AS, et al. Elevated rates of diabetes in Pacific Islanders and Asian subgroups: The Diabetes Study of Northern California (DISTANCE). Diabetes Care. 2013;36(3):574-579.
38. Herman WH, Ma Y, Uwaifo G, et al. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care. 2007;30(10):2453-2457.
39. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.
40. Atherly A, Hebert PL, Maciejewski ML. An analysis of disenrollment from Medicare managed care plans by Medicare beneficiaries with diabetes. Med Care. 2005;43(5):500-506.
41. Legorreta AP, Meng YY, Leung KM, et al. Diabetes and disenrollment in a health maintenance organization setting: a 4-year longitudinal study with a matched cohort. Diabetes Care. 1999;22(9):1487-1489.
42. Gregg EW, Cheng YJ, Saydah S, et al. Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey. Diabetes Care. 2012;35(6):1252-1257.